Breaking News

Journal Research Claims ICD Leads Resulted in Deaths

March 28, 2012

St. Jude Medical says study's numbers aren't accurate.

Heart Rhythm Journal has published a new study that looks into the details behind the recall of St. Jude Medical’s Riata and Riata ST lead recalls last year. Resurfacing the issue, the study found that the faulty wires directly caused 22 deaths. There were a total of 133 deaths – 22 caused by Riata or Riata ST lead failures, five caused by Quattro Secure Lead failures (manufactured by Medtronic Inc.), and the rest caused by unspecified factors.

The U.S. Food and Drug Administration’s (FDA) recall on Dec. 21 last year was prompted by exposed wires from the protective lead casings. The study, however, shows that it was short-circuits between high voltage components rather than externalized conductors that were the typical cause of death in the 22 deaths associated with Riata. Author of the study, Dr. Robert Hauser, told the New York Times, “When I went in, I thought I would find more deaths related to externalized cables. But as it turned out, the externalized cables really didn’t factor in.”

There is some dissent from the St. Paul, Minn.-based company. St. Jude’s Chief Medical Officer Mark Carlson, M.D., claims that Hauser’s study contains errors, namely that two of the deaths had been counted twice, bringing the count to 20 rather than 22. Hauser’s peer-reviewed study gained their numbers from searching the FDA's Manufacturer and User Device Facility Device Experience database, which aggregates reports of “adverse events involving medical devices.”

Riata and Riata ST leads had been on the market since 2000 and 2005 respectively, and in that time were estimated to have been implanted in a total of 128,000 patients worldwide. Patients who have these leads implanted with their defibrillator are at risk for short-circuits—but removing the wires is not recommended as that, too, is considered high-risk. Hauser recommends that physicians pay attention "to what are the electrical signs that might help ... identify patients who are at risk" for lead shorts.
  • An FAQ on Adaptive Design for Device Trials

    An FAQ on Adaptive Design for Device Trials

    Vicki Anastasi, Vice President and Global Head, Medical Devices & Diagnostics Research, ICON plc||November 9, 2016
    This “Ask the Experts” style article provides insights regarding common questions posed about this trial strategy.

  • Georgia Facility Lends a Commercial Eye to Medical Innovation

    Georgia Facility Lends a Commercial Eye to Medical Innovation

    Sam Brusco, Associate Editor||November 7, 2016
    Atlanta's Global Center for Medical Innovation guides medtech developers from breakthrough concepts to commercial products.

  • Where Are Your ‘Attack’ Vectors?

    Where Are Your ‘Attack’ Vectors?

    Vicki A. Barbur, Ph.D.||November 4, 2016
    Cybersecurity is of critical importance to not only medical devices, but the manufacturing floor as well. Are you prepared?